Aethlon Medical Announces Institutional Review Board Approval of Multi-Indication Cancer Study
Go back to Aethlon Medical Announces Institutional Review Board Approval of Multi-Indication Cancer Study| Aethlon Medical, Inc. (NASDAQ: AEMD) | Delayed: 0.69 +0.02 (2.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.67 | 52 Week High | $9.09 | |||
| Open | $0.69 | 52 Week Low | $4.02 | |||
| Day High | $0.69 | P/E | N/A | |||
| Day Low | $0.65 | EPS | $-0.05 | |||
| Volume | 88,178 | |||||
| (AMEX: AEMDD) | Delayed: 8.82 +0.23 (2.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.59 | 52 Week High | $15.25 | |||
| Open | $8.69 | 52 Week Low | $7.00 | |||
| Day High | $8.90 | P/E | N/A | |||
| Day Low | $8.60 | EPS | $0.00 | |||
| Volume | 21,374 | |||||
